Progyny IncPGNY
Price$24.85Intrinsic value$45.7384% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $1.3B+12.3% YoYTTM through 30 Jun 2026
Net Income $78.6M+44.7% YoYTTM through 30 Jun 2026
Free Cash Flow $178.4MTTM through 30 Jun 2026

Margins

Current
Gross Margin25.3%
EBITDA Margin9.0%
Operating Margin10.8%
Net Margin6.0%

Returns

17.3%ROE
11.0%ROA
26.2%ROIC

Balance Sheet Health

Debt / Equity0.00x
Current Ratio2.73x
Net Debt-$225.1Mnet cash position
Cash & Equivalents$152.6M

Quality Metrics

Altman Z-Score7.90
Piotroski F-Score8 / 9
FCF Margin13.6%
Rule of 4018.6
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25
FY2025: $1.3B
Diluted EPS$0.92TTM
'19'20'21'22'23'24'25
FY2025: $0.65

Dividend

No dividend

Capital Allocation

R&D Spend$11.8M
Capex Intensity1.7%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.